Optical Coherence Tomography of the Saphenous Vein Graft

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 760 participants.

Also called NCT05129228

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 760 participants (planned count) (from the registry)
Sponsor
St. Francis Hospital, New York (from the registry)
Registry
  • NCT NCT05129228
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05129228. Randomized; triple masking; primary purpose treatment. Start 2022-04-04 (actual); primary completion 2024-04-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Optical Coherence Tomography of the Saphenous Vein Graft
Acronym
OCTOCAB
Condition
Coronary Bypass Graft Stenosis
Intervention (Device)
OCT-guided saphenous vein CABG (coronary artery bypass grafting)
Lead sponsor
St. Francis Hospital, New York (class: other)

Record details

Record id
cardio:ct-nct05129228
Content hash
455b98f0d3b2ad7805f8bf2e5f91fe68ccc092636bc87b5079d8e733c176f758